Data from a case-control study TAT American Society of Clinical Oncology (ASCO) showed prostate cancer mortality risk declined by 50% in men taking statins for reasons unrelated to cancer, data from a case-control study showed.
According to Stephen Marcella, M.D., of the University of Medicine and Dentistry of New Jersey School of Public Health in Piscataway, […]
continue reading from " Prostate Cancer deaths lower in users of cholesterol lowering drugs "
